Cargando…

Urine S100 proteins as potential biomarkers of lupus nephritis activity

BACKGROUND: Improved, noninvasive biomarkers are needed to accurately detect lupus nephritis (LN) activity. The purpose of this study was to evaluate five S100 proteins (S100A4, S100A6, S100A8/9, and S100A12) in both serum and urine as potential biomarkers of global and renal system-specific disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Turnier, Jessica L., Fall, Ndate, Thornton, Sherry, Witte, David, Bennett, Michael R., Appenzeller, Simone, Klein-Gitelman, Marisa S., Grom, Alexei A., Brunner, Hermine I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655804/
https://www.ncbi.nlm.nih.gov/pubmed/29065913
http://dx.doi.org/10.1186/s13075-017-1444-4
_version_ 1783273606002769920
author Turnier, Jessica L.
Fall, Ndate
Thornton, Sherry
Witte, David
Bennett, Michael R.
Appenzeller, Simone
Klein-Gitelman, Marisa S.
Grom, Alexei A.
Brunner, Hermine I.
author_facet Turnier, Jessica L.
Fall, Ndate
Thornton, Sherry
Witte, David
Bennett, Michael R.
Appenzeller, Simone
Klein-Gitelman, Marisa S.
Grom, Alexei A.
Brunner, Hermine I.
author_sort Turnier, Jessica L.
collection PubMed
description BACKGROUND: Improved, noninvasive biomarkers are needed to accurately detect lupus nephritis (LN) activity. The purpose of this study was to evaluate five S100 proteins (S100A4, S100A6, S100A8/9, and S100A12) in both serum and urine as potential biomarkers of global and renal system-specific disease activity in childhood-onset systemic lupus erythematosus (cSLE). METHODS: In this multicenter study, S100 proteins were measured in the serum and urine of four cSLE cohorts and healthy control subjects using commercial enzyme-linked immunosorbent assays. Patients were divided into cohorts on the basis of biospecimen availability: (1) longitudinal serum, (2) longitudinal urine, (3) cross-sectional serum, and (4) cross-sectional urine. Global and renal disease activity were defined using the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and the SLEDAI-2K renal domain score. Nonparametric testing was used for statistical analysis, including the Wilcoxon signed-rank test, Kruskal-Wallis test, Mann-Whitney U test, and Spearman’s rank correlation coefficient. RESULTS: All urine S100 proteins were elevated in patients with active LN compared with patients with active extrarenal disease and healthy control subjects. All urine S100 protein levels decreased with LN improvement, with S100A4 demonstrating the most significant decrease. Urine S100A4 levels were also higher with proliferative LN than with membranous LN. S100A4 staining in the kidney localized to mononuclear cells, podocytes, and distal tubular epithelial cells. Regardless of the S100 protein tested, serum levels did not change with cSLE improvement. CONCLUSIONS: Higher urine S100 levels are associated with increased LN activity in cSLE, whereas serum S100 levels do not correlate with disease activity. Urine S100A4 shows the most promise as an LN activity biomarker, given its pronounced decrease with LN improvement, isolated elevation in urine, and positive staining in resident renal cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1444-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5655804
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56558042017-10-31 Urine S100 proteins as potential biomarkers of lupus nephritis activity Turnier, Jessica L. Fall, Ndate Thornton, Sherry Witte, David Bennett, Michael R. Appenzeller, Simone Klein-Gitelman, Marisa S. Grom, Alexei A. Brunner, Hermine I. Arthritis Res Ther Research Article BACKGROUND: Improved, noninvasive biomarkers are needed to accurately detect lupus nephritis (LN) activity. The purpose of this study was to evaluate five S100 proteins (S100A4, S100A6, S100A8/9, and S100A12) in both serum and urine as potential biomarkers of global and renal system-specific disease activity in childhood-onset systemic lupus erythematosus (cSLE). METHODS: In this multicenter study, S100 proteins were measured in the serum and urine of four cSLE cohorts and healthy control subjects using commercial enzyme-linked immunosorbent assays. Patients were divided into cohorts on the basis of biospecimen availability: (1) longitudinal serum, (2) longitudinal urine, (3) cross-sectional serum, and (4) cross-sectional urine. Global and renal disease activity were defined using the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and the SLEDAI-2K renal domain score. Nonparametric testing was used for statistical analysis, including the Wilcoxon signed-rank test, Kruskal-Wallis test, Mann-Whitney U test, and Spearman’s rank correlation coefficient. RESULTS: All urine S100 proteins were elevated in patients with active LN compared with patients with active extrarenal disease and healthy control subjects. All urine S100 protein levels decreased with LN improvement, with S100A4 demonstrating the most significant decrease. Urine S100A4 levels were also higher with proliferative LN than with membranous LN. S100A4 staining in the kidney localized to mononuclear cells, podocytes, and distal tubular epithelial cells. Regardless of the S100 protein tested, serum levels did not change with cSLE improvement. CONCLUSIONS: Higher urine S100 levels are associated with increased LN activity in cSLE, whereas serum S100 levels do not correlate with disease activity. Urine S100A4 shows the most promise as an LN activity biomarker, given its pronounced decrease with LN improvement, isolated elevation in urine, and positive staining in resident renal cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1444-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-24 2017 /pmc/articles/PMC5655804/ /pubmed/29065913 http://dx.doi.org/10.1186/s13075-017-1444-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Turnier, Jessica L.
Fall, Ndate
Thornton, Sherry
Witte, David
Bennett, Michael R.
Appenzeller, Simone
Klein-Gitelman, Marisa S.
Grom, Alexei A.
Brunner, Hermine I.
Urine S100 proteins as potential biomarkers of lupus nephritis activity
title Urine S100 proteins as potential biomarkers of lupus nephritis activity
title_full Urine S100 proteins as potential biomarkers of lupus nephritis activity
title_fullStr Urine S100 proteins as potential biomarkers of lupus nephritis activity
title_full_unstemmed Urine S100 proteins as potential biomarkers of lupus nephritis activity
title_short Urine S100 proteins as potential biomarkers of lupus nephritis activity
title_sort urine s100 proteins as potential biomarkers of lupus nephritis activity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655804/
https://www.ncbi.nlm.nih.gov/pubmed/29065913
http://dx.doi.org/10.1186/s13075-017-1444-4
work_keys_str_mv AT turnierjessical urines100proteinsaspotentialbiomarkersoflupusnephritisactivity
AT fallndate urines100proteinsaspotentialbiomarkersoflupusnephritisactivity
AT thorntonsherry urines100proteinsaspotentialbiomarkersoflupusnephritisactivity
AT wittedavid urines100proteinsaspotentialbiomarkersoflupusnephritisactivity
AT bennettmichaelr urines100proteinsaspotentialbiomarkersoflupusnephritisactivity
AT appenzellersimone urines100proteinsaspotentialbiomarkersoflupusnephritisactivity
AT kleingitelmanmarisas urines100proteinsaspotentialbiomarkersoflupusnephritisactivity
AT gromalexeia urines100proteinsaspotentialbiomarkersoflupusnephritisactivity
AT brunnerherminei urines100proteinsaspotentialbiomarkersoflupusnephritisactivity